Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial
Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag updates from v3.6.3 to v3.6.4, indicating a minor version update to the record history page.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe Record History now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor update to the page metadata rather than substantive study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe revision in the history was updated to v3.6.2, replacing the previous v3.6.0. This indicates a small metadata update to the page's revision record.SummaryDifference0.0%

- Check58 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not seeking participants. A new revision label 'v3.6.0' is added and the previous 'v3.5.5' revision is deleted.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed from the history.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision v3.5.4 was added to the history, replacing the previous v3.5.3.SummaryDifference0.0%

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.